Griseofulvin (Rising Pharmaceuticals, Inc)
Welcome to the PulseAid listing for the Griseofulvin drug offered from Rising Pharmaceuticals, Inc. This Decreased Mitosis [PE],Microtubule Inhibition [PE],Tubulin Inhibiting Agent [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | Rising Pharmaceuticals, Inc |
NON-PROPRIETARY NAME: | Griseofulvin |
SUBSTANCE NAME: | GRISEOFULVIN |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | Decreased Mitosis [PE],Microtubule Inhibition [PE],Tubulin Inhibiting Agent [EPC] |
ROUTE: | ORAL |
DOSAGE FORM: | TABLET |
MARKETING CATEGORY NAME: | ANDA |
START MARKETING DATE: | 2012-11-15 |
END MARKETING DATE: | 0000-00-00 |
Griseofulvin HUMAN PRESCRIPTION DRUG Details:
Item Description | Griseofulvin from Rising Pharmaceuticals, Inc |
LABELER NAME: | Rising Pharmaceuticals, Inc |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 125(mg/1) |
START MARKETING DATE: | 2012-11-15 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 64980-184_22d339ea-953f-4ef5-8f40-e3c2c7f41861 |
PRODUCT NDC: | 64980-184 |
APPLICATION NUMBER: | ANDA202545 |
Other GRISEOFULVIN Pharmaceutical Manufacturers / Labelers: